Cross-validated PLS-DA modeling statistics for the prediction performance for NA-SERS typing of individual type 2V <i>M</i>. <i>pneumoniae</i> clinical isolates.

Three categories were incorporated to cross-validate the model: either type 1; type 2; or neither. Clinical isolates were treated as an unknown class and cross-validated sensitivity, specificity, and class error were based on their classification prediction score as neither type 1 or type 2 reference control strains (i.e. category 3). Cross-validated PLS-DA modeling statistics for the prediction performance for NA-SERS typing of individual type 2V M. pneumoniae clinical isolates.